Follow
Zahra Madjd
Zahra Madjd
Professor, Dep pathology and Head, Dep Molecular Medicine Iran University of Medical sciences
Verified email at iums.ac.ir
Title
Cited by
Cited by
Year
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis
NFS Watson, JM Ramage, Z Madjd, I Spendlove, IO Ellis, JH Scholefield, ...
International journal of cancer 118 (1), 6-10, 2006
3112006
Expression of the stress‐related MHC class I chain‐related protein MICA is an indicator of good prognosis in colorectal cancer patients
NFS Watson, I Spendlove, Z Madjd, R McGilvray, AR Green, IO Ellis, ...
International journal of cancer 118 (6), 1445-1452, 2006
2052006
Total loss of MHC class I is an independent indicator of good prognosis in breast cancer
Z Madjd, I Spendlove, SE Pinder, IO Ellis, LG Durrant
International journal of cancer 117 (2), 248-255, 2005
1792005
CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours
Z Madjd, A Zare Mehrjerdi, AM Sharifi, S Molanaei, SZ Shahzadi, ...
Cancer immunity 9 (1), 2009
1392009
High expression of Lewisy/bantigens is associated with decreased survival in lymph node negative breast carcinomas
Z Madjd, T Parsons, NFS Watson, I Spendlove, I Ellis, LG Durrant
Breast Cancer Research 7, 1-8, 2005
1252005
The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease
P Rolland, Z Madjd, L Durrant, IO Ellis, R Layfield, I Spendlove
Endocrine-related cancer 14 (1), 73-80, 2007
1212007
Apelin-13 protects the brain against ischemic reperfusion injury and cerebral edema in a transient model of focal cerebral ischemia
M Khaksari, N Aboutaleb, F Nasirinezhad, A Vakili, Z Madjd
Journal of Molecular Neuroscience 48, 201-208, 2012
972012
Upregulation of MICA on high-grade invasive operable breast carcinoma
Z Madjd, I Spendlove, R Moss, S Bevin, SE Pinder, NFS Watson, I Ellis, ...
Cancer immunity 7 (1), 2007
962007
Co-expression of cancer stem cell markers OCT4 and NANOG predicts poor prognosis in renal cell carcinomas
A Rasti, M Mehrazma, Z Madjd, M Abolhasani, L Saeednejad Zanjani, ...
Scientific reports 8 (1), 11739, 2018
942018
Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy
M Naseri, M Bozorgmehr, M Zöller, E Ranaei Pirmardan, Z Madjd
Oncoimmunology 9 (1), 1779991, 2020
902020
Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients
NFS Watson, LG Durrant, Z Madjd, IO Ellis, JH Scholefield, I Spendlove
Cancer Immunology, Immunotherapy 55, 973-980, 2006
902006
Differential expression of cancer stem cell markers ALDH1 and CD133 in various lung cancer subtypes
R Roudi, A Korourian, A Shariftabrizi, Z Madjd
Cancer investigation 33 (7), 294-302, 2015
882015
Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease
F Bokharaei‐Salim, H Keyvani, SHR Monavari, SM Alavian, Z Madjd, ...
Journal of Medical Virology 83 (6), 989-995, 2011
802011
Loss of CD59 expression in breast tumours correlates with poor survival
Z Madjd, SE Pinder, C Paish, IO Ellis, J Carmichael, LG Durrant
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
802003
3D protein-based bilayer artificial skin for the guided scarless healing of third-degree burn wounds in vivo
M Gholipourmalekabadi, AM Seifalian, AM Urbanska, MD Omrani, ...
Biomacromolecules 19 (7), 2409-2422, 2018
782018
ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder
H Keymoosi, E Gheytanchi, M Asgari, A Shariftabrizi, Z Madjd
Asian Pacific Journal of Cancer Prevention 15 (5), 2013-2020, 2014
742014
The p53 Positive Bcl-2 Negative Phenotype is an independent marker of prognosis in breast cancer
P Rolland, I Spendlove, Z Madjd, EA Rakha, P Poulam, IO Ellis, L Durrant
International J Cancer 120 (6), 1311-7, 2006
742006
Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines
E Gheytanchi, M Naseri, F Karimi-Busheri, F Atyabi, ES Mirsharif, ...
Cancer cell international 21, 1-16, 2021
662021
Evidence that the p53 negative/Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients
NFS Watson, Z Madjd, D Scrimegour, I Spendlove, IO Ellis, JH Scholefield, ...
World journal of surgical oncology 3, 1-10, 2005
652005
Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer
R Roudi, Z Madjd, A Korourian, M Mehrazma, S Molanae, MN Sabet, ...
Cancer biomarkers 14 (6), 457-467, 2014
602014
The system can't perform the operation now. Try again later.
Articles 1–20